Sonoma Pharmaceuticals (SNOA) Asset Writedowns and Impairment (2011 - 2015)
Sonoma Pharmaceuticals (SNOA) posted quarterly Asset Writedowns and Impairment of -$834000.0 for Q1 2015, down 117.94% quarter-over-quarter from $4.6 million in Q4 2014.
Sonoma Pharmaceuticals (SNOA) Asset Writedowns and Impairment (2011 - 2015) Analysis & Trends
Sonoma Pharmaceuticals' Asset Writedowns and Impairment history runs 5 years deep, the most recent figure standing at -$834000.0 for Q1 2015.
- In Q1 2015, Asset Writedowns and Impairment changed N/A year-over-year to -$834000.0; the TTM figure through Mar 2015 stood at $3.8 million (changed N/A YoY), while the FY2022 annual figure was -$125000.0, up 86.16% from the prior year.
- Asset Writedowns and Impairment for Q1 2015 stood at -$834000.0, down from $4.6 million in the prior quarter.
- The five-year high for Asset Writedowns and Impairment was $4.6 million in Q4 2014, with the low at -$834000.0 in Q1 2015.
- The 5-year median for Asset Writedowns and Impairment is $104000.0 (2011), against an average of $331666.7.
- The sharpest annual moves came in 2012 and 2013: Asset Writedowns and Impairment soared 158.62% in 2012, then plunged 73.63% in 2013.
- Sonoma Pharmaceuticals' Asset Writedowns and Impairment stood at $128000.0 in 2011, then advanced by 23.44% to $158000.0 in 2012, then slumped by 84.81% to $24000.0 in 2013, then jumped by 19275.0% to $4.6 million in 2014, then slumped by 117.94% to -$834000.0 in 2015.
- Business Quant data shows SNOA's Asset Writedowns and Impairment at -$834000.0 in Q1 2015, $4.6 million in Q4 2014, and $24000.0 in Q3 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Sonoma Pharmaceuticals | 5.17 Mn | -165,129.89 | 2.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2015 | -834,000.00 |
| Mar 31, 2015 | -834,000.00 |
| Dec 31, 2014 | 4.65 Mn |
| Dec 31, 2014 | 4.65 Mn |
| Sep 30, 2013 | 24,000.00 |
| Sep 30, 2013 | 24,000.00 |
| Jun 30, 2013 | 167,000.00 |
| Jun 30, 2013 | 167,000.00 |
| Mar 31, 2013 | -428,000.00 |
| Mar 31, 2013 | -428,000.00 |
| Dec 31, 2012 | 158,000.00 |
| Dec 31, 2012 | 158,000.00 |
| Sep 30, 2012 | 91,000.00 |
| Sep 30, 2012 | 91,000.00 |
| Jun 30, 2012 | 150,000.00 |
| Jun 30, 2012 | 150,000.00 |
| Mar 31, 2012 | -301,000.00 |
| Mar 31, 2012 | -301,000.00 |
| Dec 31, 2011 | 128,000.00 |
| Dec 31, 2011 | 128,000.00 |